<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04111120</url>
  </required_header>
  <id_info>
    <org_study_id>INT/IEC/2019/001615</org_study_id>
    <nct_id>NCT04111120</nct_id>
  </id_info>
  <brief_title>Heparin Like Effect in Acute Variceal Bleeding</brief_title>
  <official_title>Assessment of Coagulation Profile and Role of Endogenous Heparinoids in SIRS and Sepsis in Acute Variceal Bleeding in Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study attempts to clarify the pathophysiology of haemostasis in relation to the evidence
      of sepsis in liver disease, and compares the accuracy of various available laboratory tests
      in assessment of these patients. Further research is needed for proper understanding of the
      influence of sepsis on coagulation disorders in acute variceal bleeding in cirrhosis, to
      correctly identify the type and optimal quantity of blood product requirement in at risk
      patients.

      Thromboelastography (TEG) /Sonoclot has been proposed as a superior tool to rapidly diagnose
      and help guide resuscitation with blood products. Secondly, the study of derangement in
      coagulopathy after the onset of sepsis is of paramount importance because of increased
      mortality after the onset of sepsis. In the present study, patients with cirrhosis who
      present with acute variceal bleeding, will be included in the study cohort, and will undergo
      a baseline diagnostic workup as described. They will be followed for development of any signs
      of infection after hospitalization. Then the effect of sepsis on their coagulation and
      thrombin generation response swill be assessed. Thus the effect of sepsis on the progression
      and outcome of coagulopathy in patients with acute variceal bleeding will be studied.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Generation of Endogenous Heparinoids</measure>
    <time_frame>7 days</time_frame>
    <description>Change in SONOCLOT values- global and heparinase treated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in plasma levels of Specific Coagulation Factors -VIII, X, XIII, TPA and PAI</measure>
    <time_frame>7 days</time_frame>
    <description>Specific factor assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of sonoclot parameters- ACT, PF and Peak amplitude in predicting blood product utilization</measure>
    <time_frame>7 Days</time_frame>
    <description>blood transfusion requirements</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Coagulation Disorder</condition>
  <condition>Cirrhosis, Liver</condition>
  <condition>Variceal Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Cirrhosis with variceal bleeding</arm_group_label>
    <description>Coagulation factor assays and heparinase treated SONOCLOT at Days 0,3, and 7</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cirrhosis without Bleeding</arm_group_label>
    <description>Control group of 25 subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>SONOCLOT, coagulation factor assays for VIII/X, XIII, TPA/ PAI</intervention_name>
    <description>Coagulation assessment using heparinase treated SONOCLOT</description>
    <arm_group_label>Cirrhosis with variceal bleeding</arm_group_label>
    <arm_group_label>Cirrhosis without Bleeding</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma samples will be stored for coagulation factor assays
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cirrhosis with acute variceal bleeding
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65 years

          -  Cirrhosis with acute variceal bleeding.

        Exclusion Criteria:

          -  Patients with evidence of sepsis at presentation.

          -  Current therapy: Recent blood or blood component transfusion in the last 2 weeks.

          -  HIV positive/ AIDS patients

          -  Patients requiring antiplatelet therapy,

          -  Renal insufficiency requiring dialysis

          -  Active malignancy within the last 5 years

          -  Patient with other neurological disease and metabolic disorders, unbalanced heart
             failure and/or respiratory failure or end-stage renal disease

          -  Administration of anticoagulants, antifibrinolytics,

          -  Not willing to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RK Dhiman, MD DM</last_name>
    <role>Study Chair</role>
    <affiliation>Postgraduate Institute of Medical Education and Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Madhumita Premkumar, MD DM</last_name>
    <phone>01722756344</phone>
    <email>drmadhumitap@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Postgraduate Institute of Medical Education and Research</name>
      <address>
        <city>Chandigarh</city>
        <state>Choose Any State/Province</state>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madhumita Premkumar</last_name>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>January 22, 2020</last_update_submitted>
  <last_update_submitted_qc>January 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Postgraduate Institute of Medical Education and Research</investigator_affiliation>
    <investigator_full_name>Madhumita Premkumar</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Hepatology</investigator_title>
  </responsible_party>
  <keyword>thromboelastography</keyword>
  <keyword>variceal bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

